应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。
关闭
IQV 艾昆纬
休市中 07-24 16:00:00 EDT
208.05
+0.73
+0.35%
盘后
208.05
+0.00
0.00%
19:47 EDT
最高
209.99
最低
206.92
成交量
108.98万
今开
208.14
昨收
207.32
日振幅
1.48%
总市值
349.52亿
流通市值
332.88亿
总股本
1.68亿
成交额
2.28亿
换手率
0.68%
流通股本
1.60亿
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
异动解读｜艾昆纬盘中上涨8.48%，多家投行密集上调目标价叠加二季报临近
行情直击 · 07-23 21:31
异动解读｜艾昆纬盘中上涨8.48%，多家投行密集上调目标价叠加二季报临近
异动解读｜艾昆纬盘前上涨5.78%，多家机构密集上调目标价叠加财报临近
行情直击 · 07-23 21:10
异动解读｜艾昆纬盘前上涨5.78%，多家机构密集上调目标价叠加财报临近
异动解读｜艾昆纬盘中上涨6.11%，Baird上调目标价至249美元提振市场信心
行情直击 · 07-02
异动解读｜艾昆纬盘中上涨6.11%，Baird上调目标价至249美元提振市场信心
一周美股牛榜 | Bio-Techne上周飙涨逾22%，艾伯维公司劲升逾17%，联合大陆航空涨超15%，康宁涨超13%
老虎资讯综合 · 06-29
一周美股牛榜 | Bio-Techne上周飙涨逾22%，艾伯维公司劲升逾17%，联合大陆航空涨超15%，康宁涨超13%
艾昆纬与科兴生物制药深化战略协作，借助AI赋能加速全球生物类似药开发
美股速递 · 05-14
艾昆纬与科兴生物制药深化战略协作，借助AI赋能加速全球生物类似药开发
礼来减肥药Foundayo美国处方量持续攀升 5月首周达7335份
美股速递 · 05-08
礼来减肥药Foundayo美国处方量持续攀升 5月首周达7335份
异动解读 | 艾昆纬盘中大涨5.19%，因上调年度盈利预期且一季度财报超预期
异动解读 · 05-06
异动解读 | 艾昆纬盘中大涨5.19%，因上调年度盈利预期且一季度财报超预期
艾昆纬高管：未来四至五年专利到期潮将推动制药企业加速管线补充，提升CRO服务需求
美股速递 · 05-05
艾昆纬高管：未来四至五年专利到期潮将推动制药企业加速管线补充，提升CRO服务需求
艾昆纬高管称需求环境已企稳 但大型投资方仍对资本部署持审慎态度
美股速递 · 05-05
艾昆纬高管称需求环境已企稳 但大型投资方仍对资本部署持审慎态度
异动解读 | 财报关键指标不及预期，艾昆纬盘前大跌6.79%
异动解读 · 05-05
异动解读 | 财报关键指标不及预期，艾昆纬盘前大跌6.79%
艾昆纬高管称一季度簿记对账单比率偏低源于临床实验适应症组合导致的异常低转嫁预订量——电话会议
美股速递 · 05-05
艾昆纬高管称一季度簿记对账单比率偏低源于临床实验适应症组合导致的异常低转嫁预订量——电话会议
OpenAI两大更新！推出药物研发模型挑战谷歌，发布Codex可操作电脑持续性工作
华尔街见闻 · 04-17
OpenAI两大更新！推出药物研发模型挑战谷歌，发布Codex可操作电脑持续性工作
艾昆纬发布IQVIA.AI统一智能代理平台，搭载英伟达技术提升生命科学领域效率与决策水平
美股速递 · 03-17
艾昆纬发布IQVIA.AI统一智能代理平台，搭载英伟达技术提升生命科学领域效率与决策水平
艾昆纬签署协议收购查尔斯河实验室药物发现资产，拓展端到端药物研发能力
美股速递 · 02-25
艾昆纬签署协议收购查尔斯河实验室药物发现资产，拓展端到端药物研发能力
艾昆纬与杜克临床研究所达成战略合作，共同推进肥胖及相关疾病临床研究
美股速递 · 02-10
艾昆纬与杜克临床研究所达成战略合作，共同推进肥胖及相关疾病临床研究
异动解读 | 利息支出增加致利润预期疲软，艾昆纬盘中大跌5.33%
异动解读 · 02-05
异动解读 | 利息支出增加致利润预期疲软，艾昆纬盘中大跌5.33%
艾昆纬高管称客户对AI驱动创新需求加速增长 大型药企尤为显著——电话会议透露
美股速递 · 02-05
艾昆纬高管称客户对AI驱动创新需求加速增长 大型药企尤为显著——电话会议透露
艾昆纬与勃林格殷格翰宣布达成长期全球商业数据基础转型战略合作
美股速递 · 01-29
艾昆纬与勃林格殷格翰宣布达成长期全球商业数据基础转型战略合作
财报前瞻｜艾昆纬本季度营收预计增7.75%，机构观点偏多看好盈利修复
财报Agent · 01-29
财报前瞻｜艾昆纬本季度营收预计增7.75%，机构观点偏多看好盈利修复
小摩：维持IQVIA Hldgs(IQV.US)评级，由增持调整至增持评级, 目标价由240.00美元调整至232.00美元。
金融界 · 2025-02-18
小摩：维持IQVIA Hldgs(IQV.US)评级，由增持调整至增持评级, 目标价由240.00美元调整至232.00美元。
加载更多
公司概况
公司名称：
艾昆纬
所属市场：
NYSE
上市日期：
--
主营业务：
IQVIA Holdings Inc.成立于1982年。IQVIA是一家为生命科学和医疗保健行业提供临床研究服务、商业洞察和医疗保健智能的全球领先供应商。该公司致力于加速创新医疗疗法的开发和商业化，以帮助改善全球范围内的患者预后和人口健康。
发行价格：
--
{"stockData":{"symbol":"IQV","market":"US","secType":"STK","nameCN":"艾昆纬","latestPrice":208.05,"timestamp":1784923200000,"preClose":207.32,"halted":0,"volume":1089780,"hourTrading":{"tag":"盘后","latestPrice":208.05,"preClose":208.05,"latestTime":"19:47 EDT","volume":41562,"amount":8646975.05,"timestamp":1784936825599,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.003521126760563468,"floatShares":160000000,"shares":168000000,"eps":8.072599,"marketStatus":"休市中","change":0.73,"latestTime":"07-24 16:00:00 EDT","open":208.14,"high":209.99,"low":206.92,"amount":227509273.0272,"amplitude":0.014808,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.072599,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1785139200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":1368072000000,"exchange":"NYSE","adjPreClose":207.32,"preHourTrading":{"tag":"盘前","latestPrice":207.5,"preClose":207.32,"latestTime":"07:00 EDT","volume":1,"amount":207.5,"timestamp":1784890805984,"change":0.18,"changeRate":0.000868,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":208.05,"preClose":208.05,"latestTime":"19:47 EDT","volume":41562,"amount":8646975.05,"timestamp":1784936825599,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.9933686154864724,"impliedVol":0.4727,"impliedVolPercentile":0.8725},"requestUrl":"/m/hq/s/IQV","defaultTab":"news","newsList":[{"id":"1168878595","title":"异动解读｜艾昆纬盘中上涨8.48%，多家投行密集上调目标价叠加二季报临近","url":"https://stock-news.laohu8.com/highlight/detail?id=1168878595","media":"行情直击","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1168878595?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:31","pubTimestamp":1784813500,"startTime":"0","endTime":"0","summary":"7月23日，艾昆纬盘中上涨8.48%，报215.1美元/股，成交额185.6万美元。消息面上，近期多家投行密集上调艾昆纬目标价：Baird将目标价上调至252美元，HSBC和Leerink Partners均上调至240美元，Mizuho上调至230美元，Evercore ISI上调至225美元，均维持看好评级。公司将于7月28日盘前发布二季报，市场预期调整后EPS为2.72美元，提前布局情绪显著升温。（以上内容均基于市场公开消息，由程序或算法智能生成，仅作为股价异动提醒，不作为投资建议或交易依据。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116395216","title":"异动解读｜艾昆纬盘前上涨5.78%，多家机构密集上调目标价叠加财报临近","url":"https://stock-news.laohu8.com/highlight/detail?id=1116395216","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1116395216?lang=zh_cn&edition=full","pubTime":"2026-07-23 21:10","pubTimestamp":1784812245,"startTime":"0","endTime":"0","summary":"7月23日，艾昆纬盘前上涨5.78%，报210.0美元/股，成交额66.42万美元。消息面上，近期多家投行密集上调艾昆纬目标价：Leerink Partners将目标价从213美元上调至240美元，Baird上调至252美元，Mizuho上调至230美元，均维持跑赢大盘评级。此外，公司将于7月28日盘前发布二季报，市场提前布局情绪升温。管理层此前指引全年营收171.5亿至173.5亿美元，AI赋能及临床试验复苏构成中期增长逻辑。同日生命科学工具和服务板块整体走强，赛默飞世尔涨5.99%，形成板块共振。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104153734","title":"异动解读｜艾昆纬盘中上涨6.11%，Baird上调目标价至249美元提振市场信心","url":"https://stock-news.laohu8.com/highlight/detail?id=1104153734","media":"行情直击","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104153734?lang=zh_cn&edition=full","pubTime":"2026-07-02 00:05","pubTimestamp":1782921927,"startTime":"0","endTime":"0","summary":"7月2日，艾昆纬盘中上涨6.11%，报205.02美元/股，成交额1.6亿美元。消息面上，Baird于7月1日将艾昆纬目标价从230美元上调至249美元，维持\"跑赢大盘\"评级，较当前股价仍有约21%的上行空间。FactSet统计显示，分析师对该股的一致评级为\"买入\"，平均目标价224.17美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143206979","title":"一周美股牛榜 | Bio-Techne上周飙涨逾22%，艾伯维公司劲升逾17%，联合大陆航空涨超15%，康宁涨超13%","url":"https://stock-news.laohu8.com/highlight/detail?id=1143206979","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143206979?lang=zh_cn&edition=full","pubTime":"2026-06-29 10:18","pubTimestamp":1782699520,"startTime":"0","endTime":"0","summary":"默克提出每股73美元的收购要约后，Bio-Techne股价本周上涨22.5%，较该公司周三收盘价溢价24%。艾伯维斥资109亿美元收购Apogee，强化免疫学领域战略艾伯维股价本周上涨17%。联合大陆航空股价上涨，油价下跌和分析师看涨情绪提振航空股本周，联合大陆航空股价上涨15%。为了进一步提升股东价值，康宁董事会宣布派发每股0.28美元的季度股息。股息将于9月29日支付给截至8月31日登记在册的股东。","market":"us","thumbnail":"https://static.tigerbbs.com/98882962e3042a24d8295da8457c9db5","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/98882962e3042a24d8295da8457c9db5"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RVTY","TECH","GLW","IQV","CRL","UAL","GLWG","ABBV","INCY"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"1101405459","title":"艾昆纬与科兴生物制药深化战略协作，借助AI赋能加速全球生物类似药开发","url":"https://stock-news.laohu8.com/highlight/detail?id=1101405459","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101405459?lang=zh_cn&edition=full","pubTime":"2026-05-14 04:33","pubTimestamp":1778704391,"startTime":"0","endTime":"0","summary":"艾昆纬与科兴生物制药宣布扩大战略合作，旨在利用人工智能赋能的技术能力，加速全球范围内生物类似药的开发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0198837287.USD","LU0130103400.USD","BK4588","BK4585","LU0648001328.SGD","LU0648000940.SGD","LU1989764748.USD","LU0477156953.USD","LU1989764664.SGD","LU1201861165.SGD","LU0882574055.USD","IQV","LU0130102774.USD","LU1791710400.SGD","LU0528227936.USD","BK4530","LU0130517989.USD","LU1201861249.SGD","LU1261432733.SGD","LU0980610538.SGD","LU1791710582.SGD","BK4121","LU0477156797.USD","LU0130518102.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105509238","title":"礼来减肥药Foundayo美国处方量持续攀升 5月首周达7335份","url":"https://stock-news.laohu8.com/highlight/detail?id=1105509238","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1105509238?lang=zh_cn&edition=full","pubTime":"2026-05-08 19:06","pubTimestamp":1778238363,"startTime":"0","endTime":"0","summary":"根据分析师分享的艾昆纬最新数据，在截至5月1日的一周内，礼来公司减肥药物Foundayo在美国市场的处方量达到7335份。这一数字显示出该药物在医疗减肥领域的市场渗透力正在稳步提升。Foundayo作为礼来产品组合中的重要成员，其处方趋势直接反映了公司在该细分市场的战略布局成效。当前美国减肥药物市场年规模已突破百亿美元，且保持双位数增长率，这使得各家药企的市占率变化备受资本市场关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1629891620.HKD","LU1064131342.USD","LU1974910355.USD","LU2265009873.SGD","LU2236285917.USD","IE00BJT1NW94.SGD","LU1551013342.USD","LU2023251221.USD","SG9999014906.USD","IE0004445239.USD","SGXZ31699556.SGD","LU0882574139.USD","IE0004445015.USD","LU1145028129.USD","IE00B2B36J28.USD","IE00BJJMRY28.SGD","LU2237443382.USD","SG9999014880.SGD","LU1232071149.USD","LU1712237335.SGD","LU2108987350.USD","LU2552382132.HKD","BK4585","LU2168564065.EUR","LU2746668461.USD","LU2028103732.USD","LU0058720904.USD","LU2023250330.USD","SG9999014898.SGD","IE00BK4W5M84.HKD","LU1868837136.USD","SG9999001176.SGD","ELIL","LLII","LU0432979614.USD","LU2111349929.HKD","LU0234572021.USD","LU2106854487.HKD","LU0198837287.USD","LU1280957306.USD","LU2168564495.EUR","LU2213496289.HKD","LU2471134796.USD","LU1069344957.HKD","BK4533","LU1720051108.HKD","LU2089283258.USD","SG9999013999.USD","LU0323591593.USD","LU2491049909.HKD","IE00BKPKM429.USD","LU2491050071.SGD","IE00BFTCPJ56.SGD","LU0683600562.USD","LU1023059063.AUD","LLYZ","IQV","LU2237443895.HKD","BK4588","LU2746668974.SGD","LU2089284900.SGD","LU0640476718.USD","LU0353189763.USD","LU0122379950.USD","LU2361044949.HKD","SGXZ57979304.SGD","LU0133085943.USD","SG9999018857.SGD","LU2237443622.USD","LU0256863811.USD","LU0354030438.USD","IE00B7KXQ091.USD","LU2750360641.GBP","IE00BWXC8680.SGD","LU2324357040.USD","LU0109391861.USD","LU2462157665.USD","LU1057294990.SGD","BK4516","LU0964807845.USD","LLYX","LU1127390331.HKD","LU2168563687.JPY","IE00BFSS7M15.SGD","LU0061475181.USD","SG9999014914.USD","IE00B4JS1V06.HKD","LU0471298694.HKD","LU0820561818.USD","LU1868836757.USD","LU1868836591.USD","LU1291159041.SGD","LU0238689110.USD","LU1988902786.USD","LU2023250504.SGD","BK4534","LU2357305700.SGD","IE0001KFT4U8.USD","ELIS","LU2417539215.USD","LU1868836914.USD","LU0096364046.USD","LU0786609619.USD","LU1989771016.USD","LU2471134879.HKD","LU2471134952.CNY","LU2237443978.SGD","SG9999015978.USD","LU0385154629.USD","BK4599","LU0466842654.USD","LU0456855351.SGD","IE00BK4W5L77.USD","LU0354030511.USD","IE00B775H168.HKD","IE00BN29S564.USD","LU2087625088.SGD","LU2491050154.USD","GB00BDT5M118.USD","IE00BJJMRZ35.SGD","SGXZ99366536.SGD","LU2471134523.USD","LU0006306889.USD","LU0823434740.USD","LU2756315664.SGD","SGXZ81514606.USD","LU0266013472.USD","LU0289739699.SGD","LU2552382215.SGD","LU0708995401.HKD","LU0353189680.USD","LU0203201768.USD","LU0320765059.SGD","BK4581","IE00B1XK9C88.USD","LU2756315318.SGD","LU0320765992.SGD","LU2361045086.USD","LU0316494557.USD","IE0002141913.USD","LU1093756325.SGD","IE00B1BXHZ80.USD","LU0672654240.SGD","LU2552382058.USD","SG9999015952.SGD","LLY","LU0079474960.USD","LU0417517546.SGD","SG9999015986.USD","LU1548497426.USD","LU0823416689.USD","LU0882574055.USD","LU2237443465.HKD","LU2360106947.USD","LU2750360997.AUD","LU1623119135.USD","LU1551013425.SGD","LU0114720955.EUR","LU1814569148.SGD","SG9999018865.SGD","LU0225283273.USD","LU2063271972.USD","LU2461242641.AUD","IE00B4R5TH58.HKD","LU0889565916.HKD","SGXZ51526630.SGD","LU2271345857.HKD","LU0094547139.USD","LU2468319806.SGD","LU1267930730.SGD","LU0256863902.USD","LU2089984988.USD","LU0823434583.USD","LU2361044865.SGD","LU2112291526.USD","LU1366192091.USD","LU0158827948.USD","LU0109394709.USD","LU2896262040.SGD","LU2237438978.USD","IE0005OL40V9.USD","LU1804176565.USD","IE00BJLML261.HKD","LU1868837300.USD","LU0210536198.USD","LU0820561909.HKD","LU0097036916.USD","LU2168564149.EUR","LU1917777945.USD","SG9999015945.SGD","IE00BJJMRX11.SGD","LU1720051017.SGD","LU1061106388.HKD","LU1035775433.USD","LU2602419157.SGD","BK4007","LU0471298777.SGD","LU0943347566.SGD","IE0009355771.USD","SG9999001176.USD","LU1323610961.USD","LU2264538146.SGD","LU0820562030.AUD","LU1983299246.USD","LU0689472784.USD","LU0203202063.USD","LU2456880835.USD","IE00BFSS8Q28.SGD","IE00BKDWB100.SGD","LU2211815571.USD","LU0158827781.USD","LU1093756168.USD","LU2237443549.SGD","LU0787776722.HKD","LU0106261372.USD","LU2168564222.USD","SG9999017495.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1164910817","title":"异动解读 | 艾昆纬盘中大涨5.19%，因上调年度盈利预期且一季度财报超预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1164910817","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164910817?lang=zh_cn&edition=full","pubTime":"2026-05-06 01:24","pubTimestamp":1778001890,"startTime":"0","endTime":"0","summary":"艾昆纬今日盘中股价大幅上涨5.19%，引起了市场的广泛关注。消息面上，该公司在发布第一季度财报后上调了2026年全年盈利预期，将调整后每股收益预测区间从之前的12.55美元至12.85美元上调至12.65美元至12.95美元，高于分析师平均预期的12.70美元。同时，公司第一季度经调整后每股收益为2.90美元，营收达41.5亿美元，双双超出市场预期，显示出其业务表现强劲。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1179551504","title":"艾昆纬高管：未来四至五年专利到期潮将推动制药企业加速管线补充，提升CRO服务需求","url":"https://stock-news.laohu8.com/highlight/detail?id=1179551504","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1179551504?lang=zh_cn&edition=full","pubTime":"2026-05-05 21:59","pubTimestamp":1777989551,"startTime":"0","endTime":"0","summary":"艾昆纬高管指出，未来四到五年内即将到来的专利到期事件将促使制药行业加快研发管线补充步伐，从而进一步刺激对合同研究组织服务的需求增长。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0477156953.USD","BK4121","LU1989764664.SGD","LU0130102774.USD","LU0198837287.USD","LU1791710582.SGD","LU0882574055.USD","LU1989764748.USD","LU0130518102.USD","LU1261432733.SGD","LU0528227936.USD","LU1201861249.SGD","IQV","LU0980610538.SGD","LU0130517989.USD","BK4585","LU0477156797.USD","LU0648001328.SGD","LU1201861165.SGD","LU0648000940.SGD","LU1791710400.SGD","LU0130103400.USD","BK4530","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1142544774","title":"艾昆纬高管称需求环境已企稳 但大型投资方仍对资本部署持审慎态度","url":"https://stock-news.laohu8.com/highlight/detail?id=1142544774","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1142544774?lang=zh_cn&edition=full","pubTime":"2026-05-05 21:49","pubTimestamp":1777988940,"startTime":"0","endTime":"0","summary":"艾昆纬高管指出，当前市场需求环境已趋于稳定，然而大型机构投资者在资本配置策略上依然保持更为谨慎的节奏。尽管整体行业呈现复苏迹象，这些主要资金方仍倾向于采取分阶段、精细化的投资决策方式，反映出对市场波动风险的持续关注。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0198837287.USD","LU0130103400.USD","BK4588","BK4585","LU0648001328.SGD","LU0648000940.SGD","LU1989764748.USD","LU0477156953.USD","LU1989764664.SGD","LU1201861165.SGD","LU0882574055.USD","IQV","LU0130102774.USD","LU1791710400.SGD","LU0528227936.USD","BK4530","LU0130517989.USD","LU1201861249.SGD","LU1261432733.SGD","LU0980610538.SGD","LU1791710582.SGD","BK4121","LU0477156797.USD","LU0130518102.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181440449","title":"异动解读 | 财报关键指标不及预期，艾昆纬盘前大跌6.79%","url":"https://stock-news.laohu8.com/highlight/detail?id=1181440449","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181440449?lang=zh_cn&edition=full","pubTime":"2026-05-05 21:32","pubTimestamp":1777987969,"startTime":"0","endTime":"0","summary":"艾昆纬(IQV)今日盘前股价大跌6.79%，引发了市场的广泛关注。消息面上，公司公布了第一季度财报，虽然调整后每股收益和营收均超过分析师预期，但订单与开票额比率（即簿记对账单比率）为1.04倍，低于分析师的预估平均值，这一关键指标的疲软表现是导致股价下跌的主要原因。公司高管在随后的电话会议中解释称，第一季度簿记对账单比率偏低，主要源于临床实验适应症组合异常，导致转嫁预订量处于非典型的低位水平。分析师指出，这一比率数据很可能掩盖了公司整体稳健的业绩表现。","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114463867","title":"艾昆纬高管称一季度簿记对账单比率偏低源于临床实验适应症组合导致的异常低转嫁预订量——电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1114463867","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114463867?lang=zh_cn&edition=full","pubTime":"2026-05-05 21:13","pubTimestamp":1777986795,"startTime":"0","endTime":"0","summary":"艾昆纬高管在电话会议中表示，第一季度簿记对账单比率偏低的主要原因是临床实验适应症组合异常，导致转嫁预订量处于非典型低位水平。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU0130102774.USD","IQV","LU0980610538.SGD","LU0648001328.SGD","BK4530","LU1791710400.SGD","LU1201861249.SGD","LU0130103400.USD","LU0528227936.USD","LU1791710582.SGD","LU0477156953.USD","BK4585","BK4588","LU1989764664.SGD","BK4121","LU1989764748.USD","LU0648000940.SGD","LU0198837287.USD","LU0477156797.USD","LU0130518102.USD","LU1261432733.SGD","LU1201861165.SGD","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160129009","title":"OpenAI两大更新！推出药物研发模型挑战谷歌，发布Codex可操作电脑持续性工作","url":"https://stock-news.laohu8.com/highlight/detail?id=1160129009","media":"华尔街见闻","labels":["corporation","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1160129009?lang=zh_cn&edition=full","pubTime":"2026-04-17 07:06","pubTimestamp":1776380807,"startTime":"0","endTime":"0","summary":"OpenAI正式进军AI辅助药物研发领域，向谷歌等竞争对手发起挑战，并引发相关上市公司股价大幅下挫。OpenAI还宣布对旗下Codex产品进行更新，新版本支持与用户协同操控电脑，兼容更多常用工具与应用，并可记忆用户偏好、学习历史操作习惯。不过，Joy Jiao同时强调，OpenAI目前并不认为AI可以独立提出新的疾病治疗方案。Codex更新：拓展日常工具协作能力OpenAI发布Codex更新。","market":"us","thumbnail":"https://static.tigerbbs.com/760056d3ed9e8c1a595c0d9f2094cc4d","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/760056d3ed9e8c1a595c0d9f2094cc4d"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://wallstreetcn.com/articles/3770180","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"2","news_top_title":"OpenAI两大更新！推出药物研发模型挑战谷歌，发布Codex可操作电脑持续性工作","news_tag":"corporation,movement","news_rank":0,"length":0,"strategy_id":0,"source":"lsy1762389672944","symbols":["SDGR","RXRX","IQV","CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1125446291","title":"艾昆纬发布IQVIA.AI统一智能代理平台，搭载英伟达技术提升生命科学领域效率与决策水平","url":"https://stock-news.laohu8.com/highlight/detail?id=1125446291","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1125446291?lang=zh_cn&edition=full","pubTime":"2026-03-17 04:33","pubTimestamp":1773693209,"startTime":"0","endTime":"0","summary":"全球领先的生命科学数据分析服务商艾昆纬正式推出IQVIA.AI平台，该平台通过整合英伟达先进的人工智能计算能力，构建起统一的智能代理系统。这一创新架构将显著优化生命科学行业从研发到商业化的全流程效率，赋能企业基于数据驱动实现更精准的战略决策。通过英伟达高性能算力的加持，IQVIA.AI能够快速处理海量医疗数据，并生成可操作的智能洞察。随着人工智能在生命科学领域的深度融合，IQVIA.AI平台或将成为行业数字化转型的重要基础设施。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2242649171.HKD","BK4550","LU0130102774.USD","LU0477156797.USD","LU1366333091.USD","IE00BK4W5L77.USD","IE00BD6J9T35.USD","LU1803068979.SGD","LU2242650005.HKD","LU2290526834.HKD","LU2430703251.USD","LU1551013342.USD","LU0466842654.USD","LU2552382132.HKD","LU0348723411.USD","LU2092627202.USD","LU1037948541.HKD","LU0708995401.HKD","BK4608","NVDS","SGXZ23171101.USD","LU2271345857.HKD","LU0198837287.USD","LU1267930573.SGD","BK4587","LU1791710400.SGD","LU0187121727.USD","LU1064131342.USD","IE00BDCRKT87.USD","LU0210536198.USD","LU0980610538.SGD","NVD2.UK","LU0289961442.SGD","LU2237438978.USD","NVD","IE00BZ1G4Q59.USD","LU0964807845.USD","HK0000306701.USD","LU2471134796.USD","LU2092937148.SGD","LU2361044865.SGD","LU0109392836.USD","LU2430703095.HKD","NVDB","SG9999015358.SGD","LU2286300806.USD","LU0957791311.USD","BK4554","LU0390134368.USD","IE00BDRTCR15.USD","LU2462157665.USD","LU0127658192.USD","LU0057025933.USD","IE00BHPRN162.USD","LU2237957902.USD","GB00BDT5M118.USD","LU0823434583.USD","IE0004445015.USD","LU2294711713.HKD","LU2430703178.SGD","LU2360106780.USD","LU2065171402.SGD","LU1116320737.USD","LU0061474705.USD","LU1989772923.USD","IE00B3S45H60.SGD","LU0494093205.USD","LU0985320562.USD","LU1116320901.HKD","BK4503","LU2491050071.SGD","LU0096364046.USD","LU0266013472.USD","LU2168564222.USD","LU2125909759.SGD","LU0345770308.USD","LU0965508806.USD","LU1202635105.USD","LU0354030438.USD","LU2089283258.USD","BK4543","LU1571399168.USD","LU0056508442.USD","LU0342679015.USD","LU0476273544.USD","NVDS.UK","LU1935042991.SGD","LU1400636491.USD","LU2750360641.GBP","LU2491050154.USD","LU2125909593.SGD","SGXZ51526630.SGD","HK0000914686.HKD","IE000W1ABFV2.USD","LU2491049909.HKD","LU2089985449.USD","LU2746668461.USD","LU2471134523.USD","SGXZ31699556.SGD","LU1804176565.USD","IE00B775H168.HKD","LU2456880835.USD","BK4592","LU2461242641.AUD","LU1923623000.USD","LU2458330243.SGD","LU0719512351.SGD","NVII","LU0965509101.SGD","LU2357305700.SGD","SGXZ81514606.USD","LU2097344431.USD","LU0889565833.HKD","IE00BJJMRY28.SGD","LU1989764748.USD","NVDA","LU2168563687.JPY","LU0648000940.SGD","IE00BKDWB100.SGD","LU1839511570.USD","LU1645745479.HKD","BK4121","LU2125154935.USD","LU2381873111.SGD","LU2505996681.GBP","LU0786609619.USD","SGXZ99366536.SGD","LU1066051498.USD","LU2860962120.EUR","LU0081259029.USD","LU2191332357.HKD","LU0943347566.SGD","LU0345769631.USD","LU0444973449.USD","LU2125909916.SGD","LU0689626769.HKD","2NVD.UK","LU1712237335.SGD","LU1989772840.SGD","IE00B775SV38.USD","IE00BQXX3C00.GBP","LU2108987350.USD","NVD3.UK","HK0000914660.USD","LU1429558221.USD","IE00BKVL7J92.USD","LU0157215616.USD","LU0211327993.USD","LU1496350502.SGD","LU2552382215.SGD","LU0265550359.USD","LU1917777945.USD","IE0034235188.USD","IE00BK4W5M84.HKD","LU0158827948.USD","LU0683600562.USD","LU1814569148.SGD","LU0070217475.USD","LU2089284900.SGD","LU0234572021.USD","LU1852331112.SGD","IE00BJTD4V19.USD","LU0823414551.USD","LU1778281490.HKD","LU1642822529.SGD","LU0823434740.USD","SG9999014567.USD","LU0289739343.SGD","IE00B3SWFQ91.USD","LU1366192091.USD","LU0882574055.USD","LU1934455863.HKD","LU2272731600.USD","LU0094547139.USD","LU0640476718.USD","LU2211815571.USD","LU1868837300.USD","LU0203202063.USD","LU0316494557.USD","SG9999000418.SGD","BK4585","LU0787776722.HKD","LU0130517989.USD","LU0210528500.USD","LU1066051225.USD","BK4579","BK4532","LU2505996509.AUD","NVDQ","LU1261432733.SGD","LU2360107168.USD","IE0004445239.USD","LU2433249047.HKD","LU2106854487.HKD","LU1983260115.SGD","LU1069344957.HKD","3NVD.UK","LU1951200564.SGD","LU1316542783.SGD","LU1400636657.SGD","LU0417517546.SGD","LU1201861249.SGD","LU1119994496.HKD","IE0034235295.USD","LU2065170008.USD","SG9999017495.SGD","LU0477156953.USD","SG9999002224.SGD","LU1674673428.USD","LU0823414478.USD","SG9999015978.USD","LU0708994859.HKD","LU0820561818.USD","LU2028103732.USD","LU2083900584.USD","LU0096362180.USD","NVDD","LU1868837136.USD","LU0061475181.USD","LU0276348264.USD","LU1242518931.SGD","IE000ITXATA3.USD","LU2750360997.AUD","HK0000320264.USD","LU0310800379.SGD","LU1674673691.USD","LU1153585028.USD","IE00BKPKM429.USD","LU0215105999.USD","LU2756315318.SGD","LU0642271901.SGD","IE000YTNTUN2.SGD","LU1815336760.USD","IE0009356076.USD","LU2250418816.HKD","LU1244550494.USD","LU0069063385.USD","IE00BYXW3230.USD","LU2063271972.USD","IE00BQXX3F31.USD","LU0106261372.USD","LU2322448957.HKD","LU0323591593.USD","IE00B3M56506.USD","IE00B5949003.HKD","LU0942090050.USD","LU2361045086.USD","LU0354030511.USD","LU1974910355.USD","BK4614","LU1127390331.HKD","LU0274383776.USD","LU2087625088.SGD","SG9999014898.SGD","BK4548","IE00BZ199S13.USD","LU2054465674.USD","LU2247934214.USD","LU2244417387.USD","LU0267386448.USD","LU2065169927.USD","SG9999015986.USD","LU0079474960.USD","HK0000320223.HKD","LU2463028550.USD","HK0000306685.HKD","LU0234570918.USD","IE00B19Z8W00.USD","LU2087621335.USD","IE0003U64NQ7.SGD","LU2458330169.SGD","LU2125154778.USD","LU1232071149.USD","LU0061474960.USD","IE00BMPRXR70.SGD","LU0965509010.AUD","LU0557290698.USD","LU1496350171.SGD","LU0345769128.USD","SG9999014906.USD","IE00B19Z9505.USD","LU2265009873.SGD","LU1923622291.USD","LU0724617625.USD","LU1989764664.SGD","LU1084165304.USD","IE00BQXX3D17.EUR","LU1400636574.HKD","LU2413666426.HKD","BK4588","LU0011850046.USD","IE00BFSS8Q28.SGD","LU1244550577.SGD","LU0820561909.HKD","BK4567","LU2326559502.SGD","LU1934455277.USD","IE00B19Z8X17.USD","LU1623119135.USD","LU0238689110.USD","LU1721428933.USD","IE00B1BXHZ80.USD","LU1868836591.USD","LU2896262040.SGD","LU0256863811.USD","LU2487616109.SGD","BK4612","LU0048584097.USD","IE0004091025.USD","LU2471134952.CNY","LU1145028129.USD","LU0472753341.HKD","LU1720051017.SGD","LU2360032135.SGD","LU1992135472.HKD","LU2168564149.EUR","LU0170899867.USD","LU0256863902.USD","SG9999018857.SGD","LU0823421416.USD","LU1201861165.SGD","BK4598","LU1992135399.USD","LU1988902786.USD","LU0345768740.USD","NVDL","LU2264538146.SGD","LU2543165471.USD","BK4551","LU0347712357.USD","IE00B7KXQ091.USD","LU0353189680.USD","LU1861127337.USD","LU0289960550.SGD","LU2236285917.USD","IE00BN29S564.USD","IE00BFSS7M15.SGD","IE0004086264.USD","SG9999015945.SGD","LU0210533765.USD","LU1720051108.HKD","NVIW.SI","LU1242518857.USD","LU1815333072.USD","LU2473716301.USD","LU1670756490.USD","NVDX","LU0124676726.USD","LU1934455194.USD","BK4534","NVDU","BK4581","IE0009G5SDU7.USD","IE0005OL40V9.USD","LU2168564065.EUR","LU0130103400.USD","IE000KEQY171.SGD","LU2023251221.USD","IE00B1XK9C88.USD","LU1691799644.USD","LU1935042215.USD","NVDY","DIPS","LU0109391861.USD","IE00B4YYXB79.USD","LU1551013425.SGD","SG9999001424.SGD","IQV","SNVD.UK","LU0823421333.USD","LU0868494617.USD","LU1935043536.SGD","ANV","SG9999015341.SGD","LU0130518102.USD","LU2213496289.HKD","LU2452424414.USD","LU0979878070.USD","LU0029864427.USD","LU1267930490.SGD","NVDG","LU1718418525.SGD","IE0034235303.USD","LU2125909247.SGD","SG9999018865.SGD","LU0154236417.USD","LU0957808578.USD","LU0128525929.USD","BK4533","LU0175139822.USD","LU0882574139.USD","LU0107464264.USD","LU0788109477.HKD","LU0251132253.USD","LU2357125470.USD","LU0689472784.USD","LU1935042488.USD","LU1035775433.USD","LU1629891620.HKD","LU1280957306.USD","LU2413666699.HKD","SG9999014914.USD","LU1037948897.HKD","SG9999014559.SGD","LU0097036916.USD","LU0211328371.USD","BK4549","LU2420271590.USD","LU0345768153.USD","LU0320765059.SGD","LU2756315664.SGD","LU1699723380.USD","LU0965509283.SGD","LU2931357623.SGD","LU2168564495.EUR","LU0006306889.USD","LU0225283273.USD","LU1244550221.USD","IE00BJTD4N35.SGD","LU0345770993.USD","LU2249611893.SGD","LU1323610961.USD","LU2592432038.USD","IE00BMPRXQ63.HKD","LU2471134879.HKD","SG9999004303.SGD","LU1548497426.USD","SG9999014575.USD","BK4141","BK4529","LU2237957811.SGD","BK4527","LU0053666078.USD","NVDW","LU2552382058.USD","LU2272731865.HKD","LU0444971666.USD","LU1868836757.USD","BK4605","LU2361044949.HKD","LU2097344357.USD","LU1923622614.USD","LU1861215975.USD","LU1791710582.SGD","LU0310799852.SGD","IE00BJLML261.HKD","IE00BWXC8680.SGD","LU0082616367.USD","SG9999015952.SGD","LU0861579265.USD","LU2111349929.HKD","LU0265550946.USD","LU0077335932.USD","LU1935043023.USD","LU0158827781.USD","LU1951198990.SGD","LU2746668974.SGD","LU1267930730.SGD","LU2023250504.SGD","LU0308772762.SGD","LU0072462426.USD","LU0353189763.USD","SG9999014880.SGD","BK4530","LU0672654240.SGD","SG9999014542.SGD","LU2077746001.SGD","LU1066051811.HKD","LU2602419157.SGD","LU2403377893.USD","LU2272731782.SGD","LU2065171311.SGD","IE00B4JS1V06.HKD","LU1633808545.USD","SG9999002232.USD","LU0080751232.USD","LU2023250330.USD","LU1066053197.SGD","LU0511384066.AUD","IE00BJJMRX11.SGD","LU0868494708.USD","LU1821325948.USD","IE0001KFT4U8.USD","LU0528227936.USD","LU1435385759.SGD","LU2322448791.USD","LU1861220033.SGD","LU2506951792.HKD","LU0648001328.SGD","LU1914381329.SGD","LU0203201768.USD","IE00BMPRXN33.USD","LU2417539215.USD","LU1868836914.USD","LU0820562030.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1133242079","title":"艾昆纬签署协议收购查尔斯河实验室药物发现资产，拓展端到端药物研发能力","url":"https://stock-news.laohu8.com/highlight/detail?id=1133242079","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1133242079?lang=zh_cn&edition=full","pubTime":"2026-02-25 20:06","pubTimestamp":1772021181,"startTime":"0","endTime":"0","summary":"艾昆纬已正式签署协议，将收购查尔斯河实验室旗下的药物发现相关资产。此次收购旨在进一步扩展艾昆纬在药物研发领域的端到端服务能力，强化其在全球生命科学行业的技术整合与服务覆盖。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU0528227936.USD","LU1989764748.USD","LU0130103400.USD","BK4585","IQV","LU0648001328.SGD","LU0130517989.USD","LU1261432733.SGD","LU1791710582.SGD","LU0477156797.USD","LU0648000940.SGD","LU0130102774.USD","LU1201861249.SGD","LU0477156953.USD","BK4530","LU0980610538.SGD","LU0882574055.USD","BK4121","LU1989764664.SGD","LU1201861165.SGD","LU1791710400.SGD","LU0130518102.USD","LU0198837287.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129380060","title":"艾昆纬与杜克临床研究所达成战略合作，共同推进肥胖及相关疾病临床研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1129380060","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1129380060?lang=zh_cn&edition=full","pubTime":"2026-02-10 21:03","pubTimestamp":1770728609,"startTime":"0","endTime":"0","summary":"艾昆纬与杜克临床研究所宣布建立战略合作伙伴关系，旨在深化肥胖及相关并发症领域的临床研究。此次合作将整合双方在数据科学、临床运营及学术研究方面的专长，加速创新疗法的开发进程，为全球肥胖患者提供更有效的治疗方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0882574055.USD","LU0130102774.USD","IQV","LU0980610538.SGD","LU0648001328.SGD","BK4530","LU1791710400.SGD","LU1201861249.SGD","LU0130103400.USD","LU0528227936.USD","LU1791710582.SGD","LU0477156953.USD","BK4585","BK4588","LU1989764664.SGD","BK4121","LU1989764748.USD","LU0648000940.SGD","LU0198837287.USD","LU0477156797.USD","LU0130518102.USD","LU1261432733.SGD","LU1201861165.SGD","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1147442748","title":"异动解读 | 利息支出增加致利润预期疲软，艾昆纬盘中大跌5.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=1147442748","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1147442748?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:54","pubTimestamp":1770303288,"startTime":"0","endTime":"0","summary":"艾昆纬今日盘中股价大幅下跌5.33%，引发了市场关注。消息面上，公司发布了最新财务指引，预计2026年全年调整后每股收益在12.55美元至12.85美元之间，这一区间低于华尔街分析师平均预期的每股12.95美元。公司表示，利润预期疲软主要受到利息成本上升的拖累，其中包含了因融资活动和预期再融资带来的近8000万美元利息支出增长。尽管公司第四季度业绩表现强劲，营收和利润均超过市场预期，同时全年营收指引也高于分析师预估，但低于预期的利润展望仍打击了投资者信心，导致股价在交易时段内承压下行。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162052992","title":"艾昆纬高管称客户对AI驱动创新需求加速增长 大型药企尤为显著——电话会议透露","url":"https://stock-news.laohu8.com/highlight/detail?id=1162052992","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162052992?lang=zh_cn&edition=full","pubTime":"2026-02-05 22:17","pubTimestamp":1770301076,"startTime":"0","endTime":"0","summary":"在最新电话会议中，艾昆纬（IQVIA）高管指出，市场对人工智能驱动型创新的需求正呈现加速增长态势，这一趋势在客户群体中表现尤为明显，特别是大型制药企业展现出更高参与度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130103400.USD","LU0528227936.USD","LU0980610538.SGD","BK4530","BK4585","LU0477156797.USD","LU0477156953.USD","LU0648001328.SGD","LU0882574055.USD","LU0648000940.SGD","LU1201861249.SGD","BK4121","LU1791710400.SGD","LU0130518102.USD","LU1261432733.SGD","LU1989764748.USD","LU1791710582.SGD","BK4588","IQV","LU0130102774.USD","LU1201861165.SGD","LU0198837287.USD","LU1989764664.SGD","LU0130517989.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1103159725","title":"艾昆纬与勃林格殷格翰宣布达成长期全球商业数据基础转型战略合作","url":"https://stock-news.laohu8.com/highlight/detail?id=1103159725","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1103159725?lang=zh_cn&edition=full","pubTime":"2026-01-29 21:04","pubTimestamp":1769691850,"startTime":"0","endTime":"0","summary":"艾昆纬与勃林格殷格翰共同宣布，双方已就全球商业数据基础转型达成一项长期战略合作。此次合作旨在通过数据驱动的创新解决方案，重塑商业运营模式，为未来医疗健康领域的发展奠定坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0648000940.SGD","LU0198837287.USD","BK4588","LU1791710582.SGD","LU1261432733.SGD","LU0130103400.USD","LU0648001328.SGD","LU1201861165.SGD","LU1791710400.SGD","IQV","LU0477156953.USD","LU0130517989.USD","BK4530","LU0980610538.SGD","LU1989764664.SGD","LU1989764748.USD","LU0882574055.USD","BK4585","BK4121","LU0130102774.USD","LU0528227936.USD","LU0477156797.USD","LU1201861249.SGD","LU0130518102.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1148892834","title":"财报前瞻｜艾昆纬本季度营收预计增7.75%，机构观点偏多看好盈利修复","url":"https://stock-news.laohu8.com/highlight/detail?id=1148892834","media":"财报Agent","labels":["earningPreview"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1148892834?lang=zh_cn&edition=full","pubTime":"2026-01-29 10:19","pubTimestamp":1769653173,"startTime":"0","endTime":"0","summary":"艾昆纬将在2026年02月05日发布最新季度财报，市场预期本季度营收与EPS温和增长，关注毛利率与净利率的延续修复及主营板块的结构优化。市场研报对艾昆纬本季度的观点以看多为主，核心依据是收入与EPS的同步增长与利润率的延续修复。多家机构强调：本季度总收入预计42.40亿美元，同比增长7.75%；调整后EPS预计3.40美元，同比增长9.30%；EBIT预计8.71亿美元，同比增长2.37%。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"财报前瞻｜艾昆纬本季度营收预计增7.75%，机构观点偏多看好盈利修复","news_tag":"earningPreview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512016486","title":"小摩：维持IQVIA Hldgs(IQV.US)评级，由增持调整至增持评级, 目标价由240.00美元调整至232.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2512016486","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512016486?lang=zh_cn&edition=full","pubTime":"2025-02-18 23:45","pubTimestamp":1739893533,"startTime":"0","endTime":"0","summary":"小摩：维持IQVIA Hldgs(IQV.US)评级，由增持调整至增持评级, 目标价由240.00美元调整至232.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/18234548240145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["IQV"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.iqvia.com","stockEarnings":[{"period":"1week","weight":0.0087},{"period":"1month","weight":0.1208},{"period":"3month","weight":0.282},{"period":"6month","weight":-0.1158},{"period":"1year","weight":0.036},{"period":"ytd","weight":-0.077}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":0.0078},{"period":"3month","weight":0.035},{"period":"6month","weight":0.0721},{"period":"1year","weight":0.1647},{"period":"ytd","weight":0.0836}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"IQVIA Holdings Inc.成立于1982年。IQVIA是一家为生命科学和医疗保健行业提供临床研究服务、商业洞察和医疗保健智能的全球领先供应商。该公司致力于加速创新医疗疗法的开发和商业化，以帮助改善全球范围内的患者预后和人口健康。","yearOnYearQuotes":[{"month":1,"riseRate":0.692308,"avgChangeRate":0.004492},{"month":2,"riseRate":0.461538,"avgChangeRate":0.000669},{"month":3,"riseRate":0.538462,"avgChangeRate":-0.021847},{"month":4,"riseRate":0.307692,"avgChangeRate":0.008636},{"month":5,"riseRate":0.615385,"avgChangeRate":0.020442},{"month":6,"riseRate":0.714286,"avgChangeRate":0.03573},{"month":7,"riseRate":0.857143,"avgChangeRate":0.086744},{"month":8,"riseRate":0.538462,"avgChangeRate":0.00317},{"month":9,"riseRate":0.230769,"avgChangeRate":-0.034977},{"month":10,"riseRate":0.384615,"avgChangeRate":-0.000816},{"month":11,"riseRate":0.692308,"avgChangeRate":0.036781},{"month":12,"riseRate":0.538462,"avgChangeRate":0.01275}],"exchange":"NYSE","name":"艾昆纬","nameEN":"IQVIA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"艾昆纬(IQV)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供艾昆纬(IQV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"艾昆纬,IQV,艾昆纬股票,艾昆纬股票老虎,艾昆纬股票老虎国际,艾昆纬行情,艾昆纬股票行情,艾昆纬股价,艾昆纬股市,艾昆纬股票价格,艾昆纬股票交易,艾昆纬股票购买,艾昆纬股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"艾昆纬(IQV)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供艾昆纬(IQV)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}